Azmi Sarfuddin, Kunnathodi Faisal, Alotaibi Haifa F, Alhazzani Waleed, Mustafa Mohammad, Ahmad Ishtiaque, Anvarbatcha Riyasdeen, Lytras Miltiades D, Arafat Amr A
Scientific Research Center, Al Hussain bin Ali Street, Ministry of Defense Health Services, Riyadh 12485, Saudi Arabia.
Department of Family Medicine, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia.
Diagnostics (Basel). 2025 Feb 6;15(3):396. doi: 10.3390/diagnostics15030396.
This review aims to explore the clinical and research applications of artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), in understanding, predicting, and managing obesity. It assesses the use of AI tools to identify obesity-related risk factors, predict outcomes, personalize treatments, and improve healthcare interventions for obesity. A comprehensive literature search was conducted using PubMed and Google Scholar, with keywords including "artificial intelligence", "machine learning", "deep learning", "obesity", "obesity management", and related terms. Studies focusing on AI's role in obesity research, management, and therapeutic interventions were reviewed, including observational studies, systematic reviews, and clinical applications. This review identifies numerous AI-driven models, such as ML and DL, used in obesity prediction, patient stratification, and personalized management strategies. Applications of AI in obesity research include risk prediction, early detection, and individualization of treatment plans. AI has facilitated the development of predictive models utilizing various data sources, such as genetic, epigenetic, and clinical data. However, AI models vary in effectiveness, influenced by dataset type, research goals, and model interpretability. Performance metrics such as accuracy, precision, recall, and F1-score were evaluated to optimize model selection. AI offers promising advancements in obesity management, enabling more personalized and efficient care. While technology presents considerable potential, challenges such as data quality, ethical considerations, and technical requirements remain. Addressing these will be essential to fully harness AI's potential in obesity research and treatment, supporting a shift toward precision healthcare.
本综述旨在探讨人工智能(AI),特别是机器学习(ML)和深度学习(DL)在理解、预测和管理肥胖症方面的临床及研究应用。它评估了人工智能工具在识别肥胖相关风险因素、预测结果、个性化治疗以及改善肥胖症医疗干预措施方面的应用。使用PubMed和谷歌学术进行了全面的文献检索,关键词包括“人工智能”“机器学习”“深度学习”“肥胖症”“肥胖症管理”及相关术语。对聚焦于人工智能在肥胖症研究、管理和治疗干预中作用的研究进行了综述,包括观察性研究、系统评价和临床应用。本综述确定了众多由人工智能驱动的模型,如机器学习和深度学习,用于肥胖症预测、患者分层和个性化管理策略。人工智能在肥胖症研究中的应用包括风险预测、早期检测和治疗计划的个性化。人工智能促进了利用各种数据源(如基因、表观遗传和临床数据)的预测模型的开发。然而,人工智能模型的有效性各不相同,受到数据集类型、研究目标和模型可解释性的影响。评估了诸如准确性、精确性、召回率和F1分数等性能指标,以优化模型选择。人工智能在肥胖症管理方面提供了有前景的进展,能够实现更个性化和高效的护理。虽然这项技术具有相当大的潜力,但数据质量、伦理考量和技术要求等挑战仍然存在。解决这些问题对于充分发挥人工智能在肥胖症研究和治疗中的潜力、支持向精准医疗的转变至关重要。